1607 Capital Partners LLC Has $9.43 Million Position in BlackRock Health Sciences Trust $BME

1607 Capital Partners LLC increased its position in BlackRock Health Sciences Trust (NYSE:BME) by 49.5% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 229,260 shares of the company’s stock after acquiring an additional 75,958 shares during the period. 1607 Capital Partners LLC’s holdings in BlackRock Health Sciences Trust were worth $9,429,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. increased its holdings in BlackRock Health Sciences Trust by 22.2% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after buying an additional 257 shares during the last quarter. Geneos Wealth Management Inc. increased its holdings in BlackRock Health Sciences Trust by 200.0% in the second quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock worth $179,000 after buying an additional 3,266 shares during the last quarter. Envestnet Asset Management Inc. acquired a new position in BlackRock Health Sciences Trust in the third quarter worth approximately $209,000. Oppenheimer & Co. Inc. increased its holdings in BlackRock Health Sciences Trust by 5.9% in the third quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock worth $250,000 after buying an additional 373 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in BlackRock Health Sciences Trust by 108.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,450 shares of the company’s stock worth $265,000 after buying an additional 3,354 shares during the last quarter.

BlackRock Health Sciences Trust Stock Performance

NYSE:BME opened at $39.89 on Thursday. The stock’s 50 day moving average price is $39.57 and its 200 day moving average price is $40.53. BlackRock Health Sciences Trust has a 52 week low of $35.03 and a 52 week high of $42.74.

BlackRock Health Sciences Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be issued a $0.2621 dividend. The ex-dividend date is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a yield of 7.9%.

BlackRock Health Sciences Trust Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.